**Strong IPO momentum in 2026, anchored by SpaceX’s record $86 billion June listing, underpins elevated trader expectations for additional debuts before year-end.** U.S. issuers have already raised over $114 billion in traditional IPOs through mid-year, more than seven times the prior-year pace, with SPAC activity also accelerating. Multiple companies, including Holtec Nuclear (~$825 million), Orion180 Insurance (~$320 million), and Electra Therapeutics (~$325 million), have set terms for mid-September pricing on Nasdaq or NYSE, while Oura filed in September targeting a late-month window. AI-related names such as Anthropic maintain active confidential filings with potential fourth-quarter timelines, though some larger candidates like OpenAI show mixed signals on 2026 versus 2027 execution. This pipeline, combined with supportive equity valuations and sector breadth, drives market-implied probabilities for near-term listings.
Experimentelle KI-generierte Zusammenfassung mit Polymarket-Daten. Dies ist keine Handelsberatung und spielt keine Rolle bei der Auflösung dieses Marktes. · AktualisiertMistral AI closes €3 billion funding round at €21 billion valuation
Mistral AI completed a €3 billion Series D funding round in September 2026, raising its valuation to approximately €21 billion (~$24 billion). The company confirmed IPO remains a long-term possibility but no immediate plans or filings have been made.
Mistral AI raises €3 billion at €20 billion valuation, plans IPO after 2026
Mistral AI drops to 5%5%
Mistral AI closed a €3 billion funding round in mid-2026 at a €20 billion valuation, nearly doubling its previous valuation. The company confirmed IPO plans but indicated the listing would likely occur after 2026, focusing on scaling and strategic partnerships in the meantime.
































Vorsicht bei externen Links.
Vorsicht bei externen Links.
Häufig gestellte Fragen